Filing Details
- Accession Number:
- 0001562180-17-000080
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-01-03 16:01:51
- Reporting Period:
- 2017-01-01
- Filing Date:
- 2017-01-03
- Accepted Time:
- 2017-01-03 16:01:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1517022 | Akebia Therapeutics Inc. | AKBA | Pharmaceutical Preparations (2834) | 208756903 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1602396 | R. Nicole Hadas | C/O Akebia Therapeutics, Inc. 245 First Street Cambridge MA 02142 | Svp, General Counsel, Sec. | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-01-01 | 1,810 | $10.49 | 82,912 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares sold by reporting person to pay taxes in connection with the vesting of restricted stock pursuant to a December 23, 2013 award. Twenty-five percent of the shares vested on December 2, 2014, and the remaining shares vest in equal quarterly installments through October 1, 2017.
- The total amount of beneficial securities includes 807 shares of stock purchased on December 30, 2016 at $6.48 per share in connection with the Issuer's Employee Stock Purchase Plan.
Billionaire Hedge Funds
